Inspirata Receives Industry’s First FDA Clearance for Scanner Agnostic Digital Pathology Software Tampa, Florida, March 08, 2022 (GLOBE NEWSWIRE) -- Digital pathology and cancer informatics provider Inspirata announced today that it has received U.S. Food and Drug Administration (FDA) clearance...

Proposed FDA Regulatory Flexibilities Permit Primary Diagnosis with Inspirata’s Dynamyx Digital Pathology Solution Tampa, Florida, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today that pandemic-related regulatory flexibilities issued by the U.S....